Ferrata Storti Foundation

SHERPA: Unknown

People

  1. Dogan
    Dogan
  2. Epstein-Peterson
    Epstein-Peterson
  3. Horwitz
    Horwitz
  4. Levine
    Levine
  5. Salles
    Salles
  6. Stein
    Stein
  7. Stuver
    Stuver
  8. Van Den Brink
    Van Den Brink

Groups

  1. Department of Medicine (5)
  2. Hematologic Malignancies, Division of (5)
  3. Center for Hematologic Malignancies (4)
  4. Adult Leukemia (2)
  5. Executive Committee, Center for Hematologic Malignancies (2)
  6. GSK Faculty (2)
  7. GME, Medicine (1)
  8. Graduate Medical Education (1)
  9. Human Oncology and Pathogenesis Program (1)
  10. Immunology Program Faculty (1)
Search Within
  1. "Review"
Formats
  1. Review (7)
Groups
  1. Department of Medicine (5)
  2. Hematologic Malignancies, Division of (5)
  3. Center for Hematologic Malignancies (4)
  4. Adult Leukemia (2)
  5. Executive Committee, Center for Hematologic Malignancies (2)
  6. GSK Faculty (2)

More Groups

People
  1. Ahmet Dogan (1)
  2. Brian Ball (1)
  3. Eytan Stein (1)
  4. Gilles Salles (1)
  5. Kate Markey (1)
  6. Marcel Van Den Brink (1)

More People

Years
  1. 2023 (2)
  2. 2022 (1)
  3. 2021 (1)
  4. 2020 (1)
  5. 2019 (2)
Publications
  1. Haematologica (7)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Biology and genetics of extranodal mature T-cell and NK-cell lymphomas and lymphoproliferative disorders
    Review

    Lewis, N. E.; Zhou, T.; Dogan, A.
    Haematologica (2023)

    Fulltext@MSK | Save
  • Few and far between: Clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomas
    Review

    Stuver, R.; Epstein-Peterson, Z. D.; Horwitz, S. M.
    Haematologica (2023)

    Fulltext@MSK | Save
  • Indolent lymphomas: Introduction to a series highlighting progress and ongoing challenges
    Review

    Smith, S. M.; Salles, G.
    Haematologica (2022)

    Fulltext@MSK | Save
  • The post-hematopoietic cell transplantation microbiome: Relationships with transplant outcome and potential therapeutic targets
    Review

    van Lier, Y. F.; van den Brink, M. R. M.; Hazenberg, M. D.; Markey, K. A.
    Haematologica (2021)

    Fulltext@MSK | Save
  • Use of immunosuppressive therapy for management of myelodysplastic syndromes: A systematic review and meta-analysis
    Review

    Stahl, M.; Bewersdorf, J. P.; Giri, S.; Wang, R.; Zeidan, A. M.
    Haematologica (2020)

    Fulltext@MSK | Save
  • Which are the most promising targets for minimal residual disease-directed therapy in acute myeloid leukemia prior to allogeneic stem cell transplant?
    Review

    Ball, B.; Stein, E. M.
    Haematologica (2019)

    Fulltext@MSK | Save
  • Next-generation sequencing in the diagnosis and minimal residual disease assessment of acute myeloid leukemia
    Review

    Levine, R. L.; Valk, P. J. M.
    Haematologica (2019)

    Fulltext@MSK | Save

    • Ferrata Storti Foundation – authorized name for: